Concepedia

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

Alan F. Barker, Anne E. O’Donnell, Patrick A. Flume, Philip J. Thompson, Jonathan Ruzi, Wim Boersma, Anthony De Soyza, Lixin Shao, Jenny Zhang, Laura Haas,

The Lancet Respiratory Medicine · 2014 · 216 citations · 21 references

DOI

Concepts

References

21

The Bronchiectasis Severity Index. An International Derivation and Validation Study

James D. Chalmers, Pieter Goeminne, Stefano Aliberti et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 1.1K citations · Full text

, , +15

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial

Conroy Wong, Lata Jayaram, Noel Karalus et al. · The Lancet · 2012 · 589 citations

, , +8

Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis

Josje Altenburg, Casper S. de Graaff, Ymkje Stienstra et al. · JAMA · 2013 · 492 citations

, , +14

Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I

Anne E. O’Donnell, Alan F. Barker, Jonathan Ilowite et al. · CHEST Journal · 1998 · 440 citations · Full text

, , +12

Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis

David J. Serisier, Megan Martin, Michael A. McGuckin et al. · JAMA · 2013 · 410 citations

, , +15